NAD+ and Exercise in FA (ExRx in FA) – Nicotinamide Riboside (NR)
|Mar 19 2024
A Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Friedreich Ataxia (MOVE-FA)
|Mar 19 2024
A Study of Vatiquinone for the Treatment of Participants with Friedreich’s Ataxia
|Mar 19 2024
A Pilot Investigator Initiated Study to Evaluate the Safety, Tolerability and Efficacy of Elamipretide in the Treatment of Advanced Symptoms of Friedreich Ataxia (FRDA)
|Mar 19 2024
A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects with Friedreich’s Ataxia – CTI-1601